Somatostatinoma Terminated Phase 2 Trials for Romidepsin (DB06176)

Also known as: Somatostatinomas

IndicationStatusPhase
DBCOND0000820 (Somatostatinoma)Terminated2
clinicaltrials.gov IdentifierTitlePurposeDrugs
NCT00084461Romidepsin in Treating Patients With Locally Advanced or Metastatic Neuroendocrine TumorsTreatment